Liver fibrosis in patients with non-alcoholic fatty liver disease: diagnostic options in clinical practice

Bibliography

• Younossi ZM, Stepanova M, Afendy M, Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011;9(6):524-30
   PubMed Web of Science ®Google Scholar
• Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008;28(4):339-50
   PubMed Web of Science ®Google Scholar
• Ertle J, Dechene A, Sowa JP, Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer 2010;128:2436-43
   Web of Science ®Google Scholar
• Dam-Larsen S, Franzmann M, Andersen IB, Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004;53:750-5
   PubMed Web of Science ®Google Scholar
• Ekstedt M, Franzen LE, Mathiesen UL, Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44(4):865-73
   PubMed Web of Science ®Google Scholar
• Soderberg C, Stal P, Askling J, Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010;51(2):595-602
   PubMed Web of Science ®Google Scholar
• Angulo P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 2010;51(2):373-5
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Cassader M, Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43(8):617-49
   PubMed Web of Science ®Google Scholar
• Ratziu V, Bellentani S, Cortez-Pinto H, A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010;53(2):372-84
   PubMed Web of Science ®Google Scholar
• Alisi A, Locatelli M, Nobili V. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care 2010;13(4):397-402
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41(6):1313-21
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Brunt EM, Kleiner DE, Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 2011;54(1):344-53
   PubMedGoogle Scholar
• Younossi ZM, Stepanova M, Rafiq N, Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 2011;53(6):1874-82
   PubMed Web of Science ®Google Scholar
• Castera L, Negre I, Samii K, Pain experienced during percutaneous liver biopsy. Hepatology 1999;30(6):1529-30
   PubMed Web of Science ®Google Scholar
• Poynard T, Lebrec D. The inconvenience of investigations used in hepatology: patients' and hepatologists' opinions. Liver 1982;2(4):369-75
   PubMedGoogle Scholar
• Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344(7):495-500
   PubMed Web of Science ®Google Scholar
• Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38(6):1449-57
   PubMed Web of Science ®Google Scholar
• Merriman RB, Ferrell LD, Patti MG, Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006;44(4):874-80
   PubMed Web of Science ®Google Scholar
• Ratziu V, Charlotte F, Heurtier A, Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128(7):1898-906
   PubMed Web of Science ®Google Scholar
• Vuppalanchi R, Unalp A, Natta ML, Effects of liver biopsy sample length and number of readings on histologic yield for nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7(4):481-6
   PubMed Web of Science ®Google Scholar
• Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol 2009;50(1):1-3
   PubMed Web of Science ®Google Scholar
• de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008;48(Suppl 1):S104-12
   PubMed Web of Science ®Google Scholar
• Sandrin L, Fourquet B, Hasquenoph JM, Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29(12):1705-13
   PubMed Web of Science ®Google Scholar
• Brunt EM, Janney CG, Di Bisceglie AM, Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94(9):2467-74
   PubMed Web of Science ®Google Scholar
• Poynard T, Halfon P, Castera L, Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 2007;53(9):1615-22
   PubMed Web of Science ®Google Scholar
• Wong VW, Vergniol J, Wong GL, Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010;51(2):454-62
   PubMed Web of Science ®Google Scholar
• Boursier J, Cales P. Clinical interpretation of Fibroscan(R) results: a real challenge. Liver Int 2010;30(10):1400-2
   PubMed Web of Science ®Google Scholar
• Arena U, Vizzutti F, Corti G, Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47(2):380-4
   PubMed Web of Science ®Google Scholar
• Sagir A, Erhardt A, Schmitt M, Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008;47(2):592-5
   PubMed Web of Science ®Google Scholar
• Coco B, Oliveri F, Maina AM, Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14(5):360-9
   PubMed Web of Science ®Google Scholar
• Millonig G, Reimann FM, Friedrich S, Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008;48(5):1718-23
   PubMed Web of Science ®Google Scholar
• Yashima Y, Tsujino T, Masuzaki R, Increased liver elasticity in patients with biliary obstruction. J Gastroenterol 2011;46(1):86-91
   PubMed Web of Science ®Google Scholar
• Millonig G, Friedrich S, Adolf S, Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010;52(2):206-10
   PubMed Web of Science ®Google Scholar
• Mederacke I, Wursthorn K, Kirschner J, Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int 2009;29(10):1500-6
   PubMed Web of Science ®Google Scholar
• Lupsor M, Badea R, Stefanescu H, Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients. J Gastrointestin Liver Dis 2008;17(2):155-63
   PubMed Web of Science ®Google Scholar
• Ziol M, Kettaneh A, Ganne-Carrie N, Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis. Eur J Gastroenterol Hepatol 2009;21(11):1261-8
   PubMed Web of Science ®Google Scholar
• Sanchez-Conde M, Montes Ramirez ML, Bellon Cano JM, Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus. J Viral Hepat 2011;18(7):e278-83
   PubMed Web of Science ®Google Scholar
• Arena U, Vizzutti F, Abraldes JG, Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008;57(9):1288-93
   PubMed Web of Science ®Google Scholar
• Kim SU, Kim do Y, Ahn SH, The impact of steatosis on liver stiffness measurement in patients with chronic hepatitis B. Hepatogastroenterology 2010;57(101):832-8
   PubMed Web of Science ®Google Scholar
• Yoneda M, Yoneda M, Mawatari H, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008;40(5):371-8
   PubMedGoogle Scholar
• Lupsor M, Badea R, Stefanescu H, Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointestin Liver Dis 2010;19(1):53-60
   PubMed Web of Science ®Google Scholar
• Petta S, Di Marco V, Camma C, Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther 2011;33(12):1350-60
   PubMed Web of Science ®Google Scholar
• Rousselet MC, Michalak S, Dupre F, Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005;41(2):257-64
   PubMed Web of Science ®Google Scholar
• Germani G, Hytiroglou P, Fotiadu A, Assessment of fibrosis and cirrhosis in liver biopsies: an update. Semin Liver Dis 2011;31(1):82-90
   PubMed Web of Science ®Google Scholar
• Boursier J, de Ledinghen V, Zarski JP, Evaluation of liver lesions influencing Fibroscan results by new morphometric measurements: mainly but not only liver fibrosis. Hepatology 2010;52(Suppl 1):1130A
   Google Scholar
• Sasso M, Beaugrand M, de Ledinghen V, Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010;36(11):1825-35
   PubMed Web of Science ®Google Scholar
• Sasso M, Tengher-Barna I, Ziol M, Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan: validation in chronic hepatitis C. J Viral Hepatol 2012; In press
   PubMed Web of Science ®Google Scholar
• Castera L, Foucher J, Bernard PH, Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010;51(3):828-35
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003;49(1):7-18
   PubMed Web of Science ®Google Scholar
• Friedrich-Rust M, Romen D, Vermehren J, Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol 2011; In press
   PubMed Web of Science ®Google Scholar
• Myers RP, Pomier-Layrargues G, Kirsch R, Feasibility and diagnostic performance of the Fibroscan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012;2012(55):199-208
   Google Scholar
• de Ledinghen V, Wong VW, Vergniol J, Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan. J Hepatol 2011; In press
   Google Scholar
• Palmeri ML, Wang MH, Dahl JJ, Quantifying hepatic shear modulus in vivo using acoustic radiation force. Ultrasound Med Biol 2008;34(4):546-58
   PubMed Web of Science ®Google Scholar
• Palmeri ML, Wang MH, Rouze NC, Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol 2011;55:666-72
   PubMed Web of Science ®Google Scholar
• Yoneda M, Imajo K, Kirikoshi H, Acoustic radiation force-based shear stiffness and non-invasive panels of tests in Japanese patients with nonalcoholic fattly liver disease. J Hepatol 2011; In press
   PubMed Web of Science ®Google Scholar
• Friedrich-Rust M, Wunder K, Kriener S, Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 2009;252(2):595-604
   PubMed Web of Science ®Google Scholar
• Sporea I, Sirli RL, Deleanu A, Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies. Ultraschall Med 2011;32(Suppl 1):S46-52
   PubMedGoogle Scholar
• Ebinuma H, Saito H, Komuta M, Evaluation of liver fibrosis by transient elastography using acoustic radiation force impulse: comparison with Fibroscan((R)). J Gastroenterol 2011;46(10):1238-48
   PubMed Web of Science ®Google Scholar
• Colombo S, Buonocore M, Del Poggio A, Head-to-head comparison of transient elastography (TE), real-time tissue elastography (RTE), and acoustic radiation force impulse (ARFI) imaging in the diagnosis of liver fibrosis. J Gastroenterol 2012; In press
   PubMed Web of Science ®Google Scholar
• Boursier J, Isselin G, Fouchard-Hubert I, Acoustic Radiation Force Impulse: a new ultrasonographic technology for the widespread noninvasive diagnosis of liver fibrosis. Eur J Gastroenterol Hepatol 2009;22(9):1074-84
   Web of Science ®Google Scholar
• Yin M, Talwalkar JA, Glaser KJ, Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007;5(10):1207-13; e2
   PubMed Web of Science ®Google Scholar
• Huwart L, Sempoux C, Vicaut E, Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008;135(1):32-40
   PubMed Web of Science ®Google Scholar
• Muller M, Gennisson JL, Deffieux T, Quantitative viscoelasticity mapping of human liver using supersonic shear imaging: preliminary in vivo feasibility study. Ultrasound Med Biol 2009;35(2):219-29
   PubMed Web of Science ®Google Scholar
• Bavu E, Gennisson JL, Mallet V, Supersonic shear imagning is a new potent morphological non-invasive technique to assess liver fibrosis. Part II: comparison with Fibroscan. J Hepatol 2010;52(Suppl 1):S166
   Google Scholar
• Dowman JK, Tomlinson JW, Newsome PN. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steato-hepatitis. Aliment Pharmacol Ther 2011;33(5):525-40
   PubMed Web of Science ®Google Scholar
• Wai CT, Greenson JK, Fontana RJ, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38(2):518-26
   PubMed Web of Science ®Google Scholar
• Sterling RK, Lissen E, Clumeck N, Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43(6):1317-25
   PubMed Web of Science ®Google Scholar
• Harrison SA, Oliver D, Arnold HL, Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008;57(10):1441-7
   PubMed Web of Science ®Google Scholar
• Angulo P, Hui JM, Marchesini G, The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007;45(4):846-54
   PubMed Web of Science ®Google Scholar
• Imbert-Bismut F, Ratziu V, Pieroni L, Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357(9262):1069-75
   PubMed Web of Science ®Google Scholar
• Adams LA, Bulsara M, Rossi E, Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005;51(10):1867-73
   PubMed Web of Science ®Google Scholar
• Cales P, Oberti F, Michalak S, A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005;42(6):1373-81
   PubMed Web of Science ®Google Scholar
• Cales P, Laine F, Boursier J, Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol 2009;50(1):165-73
   PubMed Web of Science ®Google Scholar
• Rosenberg WM, Voelker M, Thiel R, Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004;127(6):1704-13
   PubMed Web of Science ®Google Scholar
• Cales P, de Ledinghen V, Halfon P, Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int 2008;28(10):1352-62
   PubMed Web of Science ®Google Scholar
• Adams LA, George J, Bugianesi E, Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2011;26(10):1536-43
   PubMed Web of Science ®Google Scholar
• Cales P, Veillon P, Konate A, Reproducibility of blood tests of liver fibrosis in clinical practice. Clin Biochem 2008;41(1-2):10-18
   PubMed Web of Science ®Google Scholar
• Boursier J, Konate A, Gorea G, Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol 2008;6(11):1263-9
   PubMed Web of Science ®Google Scholar
• Yilmaz Y. Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease. Aliment Pharmacol Ther 2009;30(11-12):1103-9
   PubMed Web of Science ®Google Scholar
• Wieckowska A, Zein NN, Yerian LM, In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006;44(1):27-33
   PubMed Web of Science ®Google Scholar
• Feldstein AE, Wieckowska A, Lopez AR, Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009;50(4):1072-8
   PubMed Web of Science ®Google Scholar
• Miller MH, Ferguson MA, Dillon JF. Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease. Liver Int 2011;31(4):461-73
   PubMed Web of Science ®Google Scholar
• Mato JM, Lu SC. Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers? Hepatology 2011;54(4):1115-17
   PubMed Web of Science ®Google Scholar
• Castera L, Sebastiani G, Le Bail B, Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. J Hepatol 2010;52(2):191-8
   PubMed Web of Science ®Google Scholar
• Boursier J, de Ledinghen V, Zarski JP, Comparison of 8 diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely non-invasive. Hepatology 2012;55(1):58-67
   PubMed Web of Science ®Google Scholar
• Boursier J, Bacq Y, Halfon P, Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol 2009;21:28-38
   PubMed Web of Science ®Google Scholar
• Boursier J, Cales P. Combination of fibrosis tests: sequential or synchronous? Hepatology 2009;50(2):656-7
   PubMed Web of Science ®Google Scholar
• Boursier J, Vergniol J, Sawadogo A, The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int 2009;29(10):1507-15
   PubMed Web of Science ®Google Scholar
• Cales P, Boursier J, de Ledinghen V, Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests. Gastroenterol Clin Biol 2008;32(12):1050-60
   PubMed Web of Science ®Google Scholar
• Boursier J, De Ledinghen V, Zarski J, A new combination of blood test and Fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol 2011;106(7):1255-63
   PubMed Web of Science ®Google Scholar
• Forestier J, Dumortier J, Guillaud O, Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests. Eur J Gastroenterol Hepatol 2010;22(5):532-40
   PubMed Web of Science ®Google Scholar
• Robic MA, Procopet B, Metivier S, Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol 2011;55(5):1017-24
   PubMed Web of Science ®Google Scholar
• Boursier J, Brochard C, Salvadori N, Blood fibrosis tests are more accurate than liver biopsy for the prediction of death or cirrhosis complications in patients with chronic hepatitis C. Hepatology 2011;54(Suppl 1):1269A
   Google Scholar
• Parkes J, Roderick P, Harris S, Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut 2010;59(9):1245-51
   PubMed Web of Science ®Google Scholar
• Jung KS, Kim SU, Ahn SH, Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011;53(3):885-94
   PubMed Web of Science ®Google Scholar
• Masuzaki R, Tateishi R, Yoshida H, Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 2009;49(6):1954-61
   PubMed Web of Science ®Google Scholar
• Vergniol J, Foucher J, Terrebonne E, Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011;140(7):1970-9
   PubMed Web of Science ®Google Scholar
• Boursier J, Bertrais S, Marsault P, Prediction of mortality by Fibroscan, FibroMeter and their combination in a cohort of 3,623 patients with chronic liver disease. Hepatology 2011;54(Suppl 1):1227A
   PubMedGoogle Scholar
• Azagury DE, Lautz DB. Obesity overview: epidemiology, health and financial impact, and guidelines for qualification for surgical therapy. Gastrointest Endosc Clin N Am 2011;21(2):189-201
   PubMedGoogle Scholar
• Nobili V, Vizzutti F, Arena U, Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008;48(2):442-8
   PubMed Web of Science ®Google Scholar
• Gaia S, Carenzi S, Barilli AL, Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011;54(1):64-71
   PubMed Web of Science ®Google Scholar
• Wong VW, Wong GL, Chim AM, Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. Am J Gastroenterol 2008;103(7):1682-8
   PubMed Web of Science ®Google Scholar
• Guha IN, Parkes J, Roderick P, Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 2008;47(2):455-60
   PubMed Web of Science ®Google Scholar
• Shah AG, Lydecker A, Murray K, Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7(10):1104-12
   PubMed Web of Science ®Google Scholar
• Fujii H, Enomoto M, Fukushima W, Applicability of BARD score to Japanese patients with NAFLD. Gut 2009;58(11):1566-7
   PubMed Web of Science ®Google Scholar
• McPherson S, Stewart SF, Henderson E, Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 2010;59(9):1265-9
   PubMed Web of Science ®Google Scholar
• Ruffillo G, Fassio E, Alvarez E, Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. J Hepatol 2011;54(1):160-3
   PubMed Web of Science ®Google Scholar
• Raszeja-Wyszomirska J, Szymanik B, Lawniczak M, Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol 2010;10:67
   PubMedGoogle Scholar
• Ratziu V, Massard J, Charlotte F, Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006;6:6
   PubMed Web of Science ®Google Scholar
• Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24(2):289-93
   PubMed Web of Science ®Google Scholar
• Lassailly G, Caiazzo R, Hollebecque A, Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity. Eur J Gastroenterol Hepatol 2011;23(6):499-506
   PubMed Web of Science ®Google Scholar